BIOLIT ApS: Financial statements 2023
CVR: 10068460
Source: annual report 2023, Danish Business Authority
01/06/2022 – 31/05/2023
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 973,661 and a net result of DKK 4,787,957 compared with DKK 3,164,066 the year before. That is a decrease of 59.1% compared with the year before. Equity in the 2023 report amounted to DKK 18,338,237. The solvency ratio was 63.8%.
- Gross Profit
- DKK 973,661
- Profit/Loss
- DKK 4,787,957
- Equity
- DKK 18,338,237
- Total Assets
- DKK 28,747,182
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 974 t. | 4.8 mio. | 18.3 mio. | 0 |
| 2022 | - | 2.4 mio. | 3.2 mio. | 13.6 mio. | 0 |
| 2021 | - | 1.8 mio. | 1.6 mio. | 10.4 mio. | 0 |
| 2020 | - | 1.5 mio. | 1.7 mio. | 8.8 mio. | - |
| 2019 | - | 2 mio. | 1.5 mio. | 7.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 21, 2023, Thomas Velin has joined the board of directors of BIOLIT ApS.
About BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees (2006). In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity in the 2025 report amounted to DKK 10,762,624.